戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 volume (17%), baseline PCWP (18%), SV (12%), LVEDV (16%), V0 (33%), and orthostatic tolerance (24%) (
2  was to assess the repeatability of LVEF and LVEDV from GBPS and to compare LVEF with those from PRNV
3 tware that automatically calculates LVEF and LVEDV.
4 ed, but dP/dV was reduced by 50% at baseline LVEDV, and cardiac mass tended to be reduced by 5% (P<.1
5 stiffness (dP/dV) was calculated at baseline LVEDV.
6 and LVEF (r = -0.60; P < 0.0001) and between LVEDV index and heart rate (r = -0.26; P < 0.001).
7  A significant relationship was seen between LVEDV index and LVEF (r = -0.60; P < 0.0001) and between
8  increase in left ventricular end-diastolic (LVEDV) and end-systolic volume (LVESV) as well as inters
9                                The change in LVEDV in those with versus without concentric hypertroph
10 In the placebo group, there was no change in LVEDV over the course of follow-up (change of 0.0 +/- 10
11 ass and LV mass/volume(0.67)) with change in LVEDV.
12                             The decreases in LVEDV and LVESV caused by the AT1-ant were also partiall
13 mall, but significantly greater, increase in LVEDV after 7-year follow-up.
14                        The mean reduction in LVEDV with CRT-D therapy at the 1-year follow-up was dir
15 abnormally low LVEF and 19% had an increased LVEDV index according to these test criteria.
16                                         Mean LVEDV at 4 months was 215.6 +/- 62.5 ml in the CTO PCI a
17                                     The mean LVEDV was 198 +/- 94 mL, with a mean difference of 9 +/-
18 rrelation with those obtained with cine MRI (LVEDV: r = 0.985, p < 0.001; LVESV: r = 0.994, p < 0.001
19                          The measurements of LVEDV, LVESV, EF and LV mass obtained with real-time MRI
20                             Repeatability of LVEDV measurements from GBPS is poor.
21                      MI had little effect on LVEDV but caused a 98% increase in LVESV (from 11.3 to 2
22 rall benefit for CTO PCI in terms of LVEF or LVEDV.
23 0.0001) and significantly lower mean resting LVEDV index values (P < 0.0001).
24 rtrophy was associated with larger follow-up LVEDV (P</=0.01).
25 ucing left ventricular end-diastolic volume (LVEDV) compared with placebo in patients with HF and red
26 s for left ventricular end-diastolic volume (LVEDV) index, left ventricular end-systolic volume (LVES
27 ) and left ventricular end diastolic volume (LVEDV) on cardiac magnetic resonance imaging after 4 mon
28 , SV, left ventricular end-diastolic volume (LVEDV), and left ventricular mass (by echocardiography)
29       Left ventricular end-diastolic volume (LVEDV), left ventricular endsystolic volume (LVESV), eje
30 lic volume (LVESV), LV end-diastolic volume (LVEDV), LV ejection fraction (LVEF), cardiac output, and
31 ge in left ventricular end-diastolic volume (LVEDV), was analyzed in 3 prespecified LVEF groups: >30%
32 e and left ventricular end-diastolic volume (LVEDV).
33 F > or = 41% in men and > or = 49% in women, LVEDV index < or = 76 mL/m2 in men and < or = 57 mL/m2 i

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。